MAHRIANA SINER: Open Payments
NPI 1467995845 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $769 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $68 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Medtronic, Inc. | 2 | $40 |
| Inspire Medical Systems, Inc. | 1 | $34 |
| Abbott Laboratories | 1 | $30 |
| KYOWA KIRIN, INC. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Edwards Lifesciences Corporation | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
Products named: Rybelsus, TRELEGY ELLIPTA, INSPIRE, ID NOW INSTRUMENT, SYMPLICITY G3, CRYSVITA, Ozempic, AIRSUPRA.
Industry payments across AZ — which companies pay providers there.
